Navigation Links
China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2011
Date:6/10/2011

87,290178,99327,334Total shareholders’ equity 808,8861,070,781163,520Noncontrolling interests10,72222,6113,453Total equity819,6081,093,392166,973Total liabilities and equity1,047,0341,563,598238,780CHINA CORD BLOOD CORPORATIONUNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONSFor the Three Months and Year Ended March 31, 2010 and 2011Three months ended March 31,Year ended March 31,2010201120102011RMBRMBUS$RMBRMBUS$(in thousands except per share)Revenues

70,80694,67114,457261,536339,53251,850Direct costs

(15,115)(20,001)(3,054)(65,730)(77,376)(11,816)Gross profit55,69174,67011,403195,806262,15640,034Operating expensesResearch and development

(5,816)(1,717)(262)(5,816)(6,960)(1,063)Sales and marketing

(12,553)(13,273)(2,027)(39,480)(47,583)(7,266)General and administrative

(12,421)(23,251)(3,551)(53,317)(83,794)(12,796)Total operating expenses

(30,790)(38,241)(5,840)(98,613)(138,337)(21,125)Operating income24,90136,4295,56397,193123,81918,909Other income, netInterest income

1,3652,6944116,4119,0651,384Interest expense

(619)(657)(100)(2,431)(2,606)(398)Exchange (loss)/gain

(1,020)(61)(9)(417)48674Write-off of deferred reverse  capitalization costs

---(21,566)--Others

148269414731,378210Total other (expense)/income, net

(126)2,245343(17,530)8,3231,270Income before income tax

24,77538,6745,90679,663132,14220,179Income tax expense

(7,199)(10,867)(1,660)(24,770)(33,929)(5,181)Net income17,57627,8074,24654,89398,21314,998Income attributable to noncontrolling  interests

(1,447)(1,548)(236)(5,369)(6,510)(994)Income attributable to redeemable  noncontrolling interests

---(347)--Net income attributable toshareholders16,12926,2594,01049,17791,70314,004Net income per share:Attributable to ordinary shares-Basic

0.240.350.050.821.310.20-Diluted

0.230.350.050.781.310.20
'/>"/>

SOURCE China Cord Blood Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Reportlinker Adds Industrial Biotechnology China News 1105 - Annual Subscription
2. NIST contests in China put next-gen robot technologies to the test
3. Reportlinker Adds Future of White Biotechnology in China
4. China Cord Blood Corporation to Report Fourth Quarter and Full Year Fiscal 2011 Financial Results
5. MicroConstants China Receives Endorsement of OECD GLP Compliance
6. China Botanic Exhibits All-Natural Products at the 65th PHARMACHINA Fair
7. Epichem and AR Brown Sign Exclusive Distribution Agreement for Japan, Taiwan, China and South Korea
8. Reportlinker Adds Industrial Biotechnology China News 1104
9. China Green Material Technologies, Inc. Announces Change of Auditor to Marcum Bernstein & Pinchuk LLP
10. ThermoGenesis Announces China Customer Implements Cord Blood Products
11. Reportlinker Adds China Bio-breeding Industry Report, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... May 27, 2015  The Companion Diagnostics Deals ... and unprecedented access to the partnering deals and ... companies during 2014. Using these reports, ... the partnering activities of the past year. The ... partnering and alliances deals announced worldwide.The initial chapters ...
(Date:5/27/2015)... , May 27, 2015 RXi ... company focused on discovering and developing innovative therapies ... today announced that it has commenced a public offering ... purchase shares of its common stock and overallotment ... stock. The shares of common stock, warrants and ...
(Date:5/27/2015)... , May 26, 2015 ... announced the addition of Jain PharmaBiotech,s new ... and Companies" to their offering. ... molecular diagnostics technologies that will play an ... health, pharmaceutical industry, forensics and biological warfare ...
(Date:5/27/2015)... 2015 Research and Markets( http://www.researchandmarkets.com/research/8nqqdw/global_breast ) ... Breast Cancer Monoclonal Antibodies Market Outlook 2020" ... seems to dominate the breast cancer monoclonal antibody ... molecule, Herceptin has been able to dominate this ... breast cancer cells become recalcitrant and relapsed condition ...
Breaking Biology Technology:Companion Diagnostics Deals and Alliances of 2014 2RXi Pharmaceuticals Announces Proposed Public Offering of Common Stock and Warrants 2RXi Pharmaceuticals Announces Proposed Public Offering of Common Stock and Warrants 3Global Molecular Diagnostics Market 2015-2024 - Analysis of Key Technologies, Markets and Companies 2Global Molecular Diagnostics Market 2015-2024 - Analysis of Key Technologies, Markets and Companies 3Global Breast Cancer Monoclonal Antibodies Market Outlook 2020 2Global Breast Cancer Monoclonal Antibodies Market Outlook 2020 3
... July 27 ... optimize clinical trial enrollment for life sciences companies, is ... 100 award based on their successful deployment of DecisionView ... is a web-based patient enrollment optimization solution that automates ...
... July 27 All signs point to accelerated growth in ... explosion of demand for services, central government policy continues to urge greater ... on Wednesday, September 8 , executives and managers can learn how ... , , , ...
... July 27 Article One Partners, the world,s ... $5 million round of institutional funding with Alleghany ... SE: Y), and other investors. The funding will be used ... online patent validation sector by enhancing existing products and services, ...
Cached Biology Technology:Pfizer Wins CIO 100 Award for Patient Enrollment Optimization Solution From DecisionView 2Orchestrall Sponsors 'China Business Toolbox': Brings Focus to the 'How and When' of China Market Access 2Orchestrall Sponsors 'China Business Toolbox': Brings Focus to the 'How and When' of China Market Access 3Article One Announces Completion of Funding from Alleghany Corporation 2Article One Announces Completion of Funding from Alleghany Corporation 3
(Date:5/19/2015)... May 19, 2015 ... the addition of the  "Genetic Testing Market ... (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,A recent report, Genetic ... analysis of the current and future genetic ... tests, their working principles and types are ...
(Date:5/14/2015)... 14, 2015  Verificient Technologies, Inc., a ... online remote proctoring, announced a new alliance ... and creator of the Canvas Learning Management ... companies will benefit from the seamless integration ... As a fully integrated multifactor biometrics behavioral ...
(Date:5/11/2015)... Curemark LLC, a privately held drug research ... Phase III double blind, randomized, placebo-controlled clinical trial to ... all children ages 3-8 with Autism. Previously, Curemark announced ... blinded clinical trial for CM-AT in children ages 3-8 ... enzyme chymotrypsin. This new trial will help determine whether ...
Breaking Biology News(10 mins):Global Genetic Testing Market Outlook 2018 2Verificient and Instructure Announce Alliance Partnership to Provide Online Proctoring for K-12 and Higher Education Institutions 2Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2
... largest ever to have taken place in a large ... HIV, and is the first study of this kind ... been coordinated by Javier Martínez-Picado, ICREA research professor in ... and Josep M. Miró, consultant of the Unit of ...
... binds to a neuron, how does the cell know to ... with other questions involving good sensations, the answer appears to ... appearing with a commentary in Nature Neuroscience online proposes a ... in the cell membrane and brings news of nicotine’s arrival. ...
... wild squash. The length of the day relative to ... induction of flowering in many plant species. Short day (SD) ... long night) in order to flower. These are plants that ... fall in temperate regions. Long day (LD) plants will flower ...
Cached Biology News:Identified main genetic variants involved in response to HIV 2Nicotine rush hinges on sugar in neurons 2Research identifies protein that signals flowering in squash plants 2Research identifies protein that signals flowering in squash plants 3
Human VEGF R3/Flt-4 Phycoerythrin MAb (Clone 54733)...
Immunogen: Synthetic Peptide: V(22) N G H E F E I E G E G E G R(36) Storage: -20 C, Avoid Freeze/Thaw Cycles...
Human beta IG-H3 MAb (Clone 348506) Keywords: BIGH3, betaIG-H3 Protein Family: Extracellular Matrix Molecules...
Human Siglec-9 Biotinylated Affinity Purified Pab...
Biology Products: